About 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide
2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide (PubChem CID 118710219) has the molecular formula C29H39Cl2N5O5S
and a molecular weight of 640.63 g/mol. Its IUPAC name is 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide.
Molecular Properties
| Compound Name | 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide |
| PubChem CID | 118710219 |
| Molecular Formula | C29H39Cl2N5O5S |
| Molecular Weight | 640.63 g/mol |
| Exact Mass | 639.20 |
| IUPAC Name | 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide |
| SMILES | CN(C(=O)CN(CC(=O)NCCN1CCCC1)c1cc(Cl)ccc1Oc1ccc(Cl)cc1)C1CCN(S(C)(=O)=O)CC1 |
| InChI | InChI=1S/C29H39Cl2N5O5S/c1-33(24-11-16-36(17-12-24)42(2,39)40)29(38)21-35(20-28(37)32-13-18-34-14-3-4-15-34)26-19-23(31)7-10-27(26)41-25-8-5-22(30)6-9-25/h5-10,19,24H,3-4,11-18,20-21H2,1-2H3,(H,32,37) |
| InChIKey | SRWIVNUJFOQFHI-UHFFFAOYSA-N |
| XLogP | 3.69 |
| TPSA | 102.50 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 640.63 |
| LogP ≤ 5 | 3.69 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide?
The IUPAC name of 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide (CID 118710219) is 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide.
What is the SMILES notation for 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide?
The canonical SMILES for 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide is CN(C(=O)CN(CC(=O)NCCN1CCCC1)c1cc(Cl)ccc1Oc1ccc(Cl)cc1)C1CCN(S(C)(=O)=O)CC1.
What is the InChIKey of 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide?
The InChIKey is SRWIVNUJFOQFHI-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H39Cl2N5O5S/c1-33(24-11-16-36(17-12-24)42(2,39)40)29(38)21-35(20-28(37)32-13-18-34-14-3-4-15-34)26-19-23(31)7-10-27(26)41-25-8-5-22(30)6-9-25/h5-10,19,24H,3-4,11-18,20-21H2,1-2H3,(H,32,37).
What are the key properties of 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide?
2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide has a molecular weight of 640.63 g/mol, XLogP of 3.69, 12 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[5-chloro-2-(4-chlorophenoxy)-N-[2-[methyl-(1-methylsulfonylpiperidin-4-yl)amino]-2-oxoethyl]anilino]-N-(2-pyrrolidin-1-ylethyl)acetamide is sourced from PubChem (CID 118710219), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).